In order to assess the relationship between the concentrations of S100A6, MMP-9 and CST4 in tear samples and the individual’s pathological status, we tested the correlation between the presence of the biomarkers and RA (Figure 3). This evidence concerns the gene CST4 and rheumatoid arthritis.